Article
The ISVsa3-ORF2-abh-tet(X4) circular intermediate-mediated transmission of tigecycline resistance in Escherichia coli isolates from duck farms.
Frontiers in cellular and infection microbiology - 1 Jan 2024
Jiang Chao, Yang Jie, Xiao Gang, Xiao Ning, Hu Jie, Yang Yi, Sun Zhiliang, Li Yujuan
Abstract excerpt
Tigecycline is a last-resort drug used to treat serious infections caused by multidrug-resistant bacteria. tet(X4) is a recently discovered plasmid-mediated tigecycline resistance gene that confers high-level resistance to tigecycline and other tetracyclines. Since the first discovery of tet(X4) in 2019, it has spread rapidly worldwide, and as a consequence, tigecycline has become increasingly ineffective in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
